Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
crushresearch.shop
Crush Research holds a Disclosed Labs trust grade of A (94/100), computed independently from 105 lab Certificates of Analysis (as of July 2026). That's a strong, well-documented track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is Crush Research's trust score?
Crush Research scores 94/100 (Grade A) on Disclosed Labs, from 105 lab COAs (as of July 2026).
How is Crush Research's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: July 5, 2026 · 100% pass rate
Composite score based on 105 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 105 COAs attributed to this vendor. Last recomputed 2026-07-05.
Research peptide vendor. COAs (/testing) are gated behind a customer login; we cannot index them without account access.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Tesamorelin | HPLC purity | PASS | 99.75% | ILS Labs | Lot CR-TESA20-2606-GRAY · Report CR-TESA20-2606-GRAY |
| Jul 2, 2026 | Adamax | HPLC purity | PASS | 99.8% | ILS Labs | Lot CR-ADMX-10MG-2606-1 · Report CR-ADMX-10MG-2606-1 |
| Jul 2, 2026 | BPC-157 | HPLC purity | PASS | 99.84% | ILS Labs |
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="crush-research"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/crushresearch.shop" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> ✓ Verified by Disclosed Labs — independent COA trust score </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to Crush Research's live profile at https://www.disclosedlabs.com/vendors/crushresearch.shop.
Links back to Crush Research's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| Adamax | vial | 10mg | $50.15 | $5.01 | In stock | 2026-07-05 | View → |
| BPC-157 | vial | 5mg | $24.65 | $4.93 | In stock | 2026-07-05 | View → |
| BPC-157 | vial | 10mg | $33.15 | $3.31 | In stock | 2026-07-05 | View → |
| BPC-157 | vial | 5mg | $58.65 | $11.73 | In stock | 2026-07-05 | View → |
| BPC-157 | vial | 10mg | $84.15 | $8.41 | In stock | 2026-07-05 | View → |
| BPC-157 | vial | 10mg | $135.15 | $13.52 | In stock | 2026-07-05 | View → |
| Cagrilintide | vial | 5mg | $49.67 | $9.93 | Sold out | 2026-06-07 | View → |
| Epithalon | vial | 50mg | $66.33 | $1.33 | Sold out | 2026-06-07 | View → |
| GHK-Cu | vial | 50mg | $24.65 | $0.49 | In stock | 2026-07-05 | View → |
| GHK-Cu | vial | 100mg | $33.15 | $0.33 | Sold out | 2026-07-05 | View → |
| GHK-Cu | vial | 50mg | $63.75 | $1.27 | In stock | 2026-07-05 | View → |
| GHK-Cu | vial | 100mg | $84.15 | $0.84 | Sold out | 2026-07-05 | View → |
| GHK-Cu | vial | 50mg | $92.65 | $1.85 | Sold out | 2026-07-05 | View → |
| GHK-Cu | vial | 100mg | $126.65 | $1.27 | Sold out | 2026-07-05 | View → |
| Glutathione | vial | 1500mg | $50.15 | $0.03 | Sold out | 2026-07-05 | View → |
| Ipamorelin | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
| KPV | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
| KPV | vial | 10mg | $84.15 | $8.41 | Sold out | 2026-07-05 | View → |
| Melanotan I | vial | 10mg | $33.15 | $3.31 | In stock | 2026-07-05 | View → |
| Melanotan I | vial | 10mg | $84.15 | $8.41 | In stock | 2026-07-05 | View → |
| Melanotan I | vial | 10mg | $126.65 | $12.66 | Sold out | 2026-07-05 | View → |
| Melanotan II | vial | 10mg | $33.15 | $3.31 | In stock | 2026-07-05 | View → |
| Melanotan II | vial | 10mg | $84.15 | $8.41 | In stock | 2026-07-05 | View → |
| Melanotan II | vial | 10mg | $126.65 | $12.66 | In stock | 2026-07-05 | View → |
| MOTS-c | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
| MOTS-c | vial | 40mg | $67.15 | $1.68 | Sold out | 2026-07-05 | View → |
| MOTS-c | vial | 40mg | $169.15 | $4.23 | Sold out | 2026-07-05 | View → |
| MOTS-c | vial | 40mg | $254.15 | $6.35 | Sold out | 2026-07-05 | View → |
| MOTS-C | vial | 20mg | $63.00 | $3.15 | Sold out | 2026-06-07 | View → |
| NAD+ | vial | 500mg | $41.65 | $0.08 | In stock | 2026-07-05 | View → |
| NAD+ | vial | 1000mg | $67.15 | $0.07 | In stock | 2026-07-05 | View → |
| NAD+ | vial | 500mg | $101.15 | $0.20 | Sold out | 2026-07-05 | View → |
| NAD+ | vial | 1000mg | $169.15 | $0.17 | In stock | 2026-07-05 | View → |
| NAD+ | vial | 1000mg | $254.15 | $0.25 | Sold out | 2026-07-05 | View → |
| Pinealon | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
| PT-141 | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 10mg | $41.65 | $4.17 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 15mg | $50.15 | $3.34 | In stock | 2026-07-05 | View → |
| Retatrutide | vial | 20mg | $58.65 | $2.93 | In stock | 2026-07-05 | View → |
| Retatrutide | vial | 30mg | $75.65 | $2.52 | In stock | 2026-07-05 | View → |
| Retatrutide | vial | 50mg | $109.65 | $2.19 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 15mg | $126.65 | $8.44 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 20mg | $152.15 | $7.61 | In stock | 2026-07-05 | View → |
| Retatrutide | vial | 30mg | $169.15 | $5.64 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 20mg | $237.15 | $11.86 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 30mg | $296.65 | $9.89 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 20mg | $398.65 | $19.93 | Sold out | 2026-07-05 | View → |
| Retatrutide | vial | 30mg | $509.15 | $16.97 | Sold out | 2026-07-05 | View → |
| Selank | vial | 5mg | $24.65 | $4.93 | In stock | 2026-07-05 | View → |
| Selank | vial | 5mg | $63.75 | $12.75 | In stock | 2026-07-05 | View → |
| Selank | vial | 5mg | $101.15 | $20.23 | Sold out | 2026-07-05 | View → |
| Sermorelin | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
| Tesamorelin | vial | 20mg | $75.65 | $3.78 | Sold out | 2026-07-05 | View → |
| Tesamorelin | vial | 20mg | $186.15 | $9.31 | Sold out | 2026-07-05 | View → |
| Tesamorelin | vial | 20mg | $296.65 | $14.83 | Sold out | 2026-07-05 | View → |
| Tirzepatide | vial | 20mg | $50.15 | $2.51 | In stock | 2026-07-05 | View → |
| Tirzepatide | vial | 30mg | $58.65 | $1.96 | Sold out | 2026-07-05 | View → |
| Tirzepatide | vial | 20mg | $126.65 | $6.33 | In stock | 2026-07-05 | View → |
| Tirzepatide | vial | 30mg | $152.15 | $5.07 | Sold out | 2026-07-05 | View → |
| Tirzepatide | vial | 20mg | $194.65 | $9.73 | Sold out | 2026-07-05 | View → |
| Tirzepatide | vial | 30mg | $220.15 | $7.34 | Sold out | 2026-07-05 | View → |
| Tirzepatide | vial | 20mg | $339.15 | $16.96 | Sold out | 2026-07-05 | View → |
| Vasoactive Intestinal Peptide (VIP) | vial | 10mg | $33.15 | $3.31 | Sold out | 2026-07-05 | View → |
Prices are scraped from crushresearch.shopand may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
PMB address (-0.03), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot CR-BPC10-2606-BLUE · Report CR-BPC10-2606-BLUE |
| Jul 2, 2026 | MOTS-c | HPLC purity | PASS | 99.74% | ILS Labs | Lot CR-MOTSC40-2606-BLUE · Report CR-MOTSC40-2606-BLUE |
| Jul 2, 2026 | KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | HPLC purity | PASS | 99.95% | ILS Labs | Lot CR-KLOW80-2606-YELLOW · Report CR-KLOW80-2606-YELLOW |
| Jul 2, 2026 | BPC-157 + TB-500 | HPLC purity | PASS | 99.84% | ILS Labs | Lot CR-BPCTB20-2606-GREEN · Report CR-BPCTB20-2606-GREEN |
| Jul 2, 2026 | Retatrutide | HPLC purity | PASS | 99.79% | ILS Labs | Lot CR-3XAG30-2606-Purple · Report CR-3XAG30-2606-Purple |
| Jun 27, 2026 | Epitalon | HPLC purity | PASS | 97.87% | ILS Labs | Lot CR-EPTH-10MG-2606-1 · Report CR-EPTH-10MG-2606-1 |
| Jun 26, 2026 | Melanotan I | HPLC purity | PASS | 99.46% | ILS Labs | Lot CR-MT1-10MG-2606-1 · Report CR-MT1-10MG-2606-1 |
| Jun 26, 2026 | NAD+ | HPLC purity | PASS | 97.91% | ILS Labs | Lot CR-NAD-1000MG-2606-1 · Report CR-NAD-1000MG-2606-1 |
| Jun 26, 2026 | Retatrutide | HPLC purity | PASS | 99.65% | ILS Labs | Lot CR-3XAG-30MG-2606-2 · Report CR-3XAG-30MG-2606-2 |
| Jun 26, 2026 | GHK-Cu | HPLC purity | PASS | 99.75% | ILS Labs | Lot CR-GHK-50MG-2606-1 · Report CR-GHK-50MG-2606-1 |
| Jun 26, 2026 | BPC-157 | HPLC purity | PASS | 99.87% | ILS Labs | Lot CR-BPC-5MG-2606-1 · Report CR-BPC-5MG-2606-1 |
| Jun 9, 2026 | GHK-Cu | HPLC purity | PASS | 99.57% | ILS Labs | Lot CR-GHKCU-100-2606-1 · Report CR-GHKCU-100-2606-1 |
| Jun 9, 2026 | Retatrutide | HPLC purity | PASS | 99.37% | ILS Labs | Lot CR-3XAG-30-2606-1 · Report CR-3XAG-30-2606-1 |
| Jun 5, 2026 | KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | HPLC purity | PASS | 99.65% | ILS Labs | Lot CR-KLOW-80MG-2605-1 · Report CR-KLOW-80MG-2605-1 |
| Jun 5, 2026 | GHK-Cu / KPV | HPLC purity | PASS | 99.19% | ILS Labs | Lot CR2604GHKKP60-01 · Report ACC-2026-3008 |
| Jun 5, 2026 | GHK-Cu / TB-500 / BPC-157 / KPV | HPLC purity | PASS | 99.65% | ILS Labs | Lot CR-KLOW-80MG-2605-1 · Report ACC-2026-3011 |
| Jun 1, 2026 | BPC-157 + TB-500 | HPLC purity | PASS | 99.83% | ILS Labs | Lot CR-CRWOLF20-260602-01 · Report CR-CRWOLF20-260602-01 |
| Jun 1, 2026 | MOTS-C | HPLC purity | PASS | 99.52% | ILS Labs | Lot CRMTS-10-2605-1 · Report ACC-2026-3346 |
| Jun 1, 2026 | Double Agonist | HPLC purity | PASS | 99.39% | ILS Labs | Lot CR-2XAG20-2605-1 · Report ACC-2026-3292 |
| Jun 1, 2026 | Sermorelin | HPLC purity | PASS | 98.98% | ILS Labs | Lot CR-SMLN-10MG-2605-1 · Report ACC-2026-3086 |
| Jun 1, 2026 | Triple Agonist | HPLC purity | PASS | 99.94% | ILS Labs | Lot CR-3XAG20-2605-2 · Report ACC-2026-3355 |
| Jun 1, 2026 | MOTS-C | HPLC purity | PASS | 99.93% | ILS Labs | Lot CRMTS-40-2605-2 · Report ACC-2026-3352 |
| Jun 1, 2026 | Wolverine | HPLC purity | PASS | 99.9% | ILS Labs | Lot CR-BPTB20-2605-1 · Report ACC-2026-3296 |
| Jun 1, 2026 | Melanotan II | HPLC purity | PASS | 99.78% | ILS Labs | Lot CR-MT2-10-2605-1 · Report COA-2026-73RMCX |
| Jun 1, 2026 | NAD+ | HPLC purity | PASS | 99.27% | ILS Labs | Lot CR-NAD500-2605-1 · Report COA-2026-5JQ2CV |
| Jun 1, 2026 | Selank | HPLC purity | PASS | 99.67% | ILS Labs | Lot CR-SLK5-2605-1 · Report ACC-2026-3099 |
| Jun 1, 2026 | CJC-1295 / Ipamorelin | HPLC purity | PASS | 99.78% | ILS Labs | Lot CR-CJIP10-2605-1 · Report ACC-2026-3105 |
| Jun 1, 2026 | Glutathione | HPLC purity | PASS | 98.71% | ILS Labs | Lot CRGLU-1500-2605-2 · Report COA-2026-RZEUXW |
| Jun 1, 2026 | AOD-9604 | HPLC purity | PASS | 99.46% | ILS Labs | Lot R-AOD-5-2605-1 · Report ACC-2026-3074 |
| Jun 1, 2026 | MOTS-C | HPLC purity | PASS | 99.73% | ILS Labs | Lot CR-MOTS20-2605-1 · Report ACC-2026-3102 |
| Jun 1, 2026 | BPC-157 | HPLC purity | PASS | 99.86% | ILS Labs | Lot CRBPC-10-2605-1 · Report ACC-2026-3358 |
| Jun 1, 2026 | NAD+ | HPLC purity | PASS | 99.22% | ILS Labs | Lot CR-NAD-1000MG-2605-2 · Report ACC-2026-3014 |
| Jun 1, 2026 | Semax | HPLC purity | PASS | 99.65% | ILS Labs | Lot CR-SMX-10-2605-1 · Report COA-2026-TNJQ5K |
| Jun 1, 2026 | MOTS-C | HPLC purity | PASS | 99.57% | ILS Labs | Lot CRMTS-40-2605-1 · Report ACC-2026-3349 |
| Jun 1, 2026 | KPV | HPLC purity | PASS | 99.19% | ILS Labs | Lot CR-KPV-10-2605-1 · Report ACC-2026-3083 |
| May 27, 2026 | Triple Agonist | HPLC purity | PASS | 99.81% | ILS Labs | Lot CR26043XAG15-01 · Report ACC-2026-3002 |
| May 27, 2026 | Triple Agonist | HPLC purity | PASS | 99.9% | ILS Labs | Lot CR26043XAG30-01 · Report ACC-2026-3005 |
| May 27, 2026 | Triple Agonist | HPLC purity | PASS | 99.37% | ILS Labs | Lot CR26043XAG50-01 · Report ACC-2026-2999 |
| May 20, 2026 | Triple Agonist | HPLC purity | PASS | 99.79% | ILS Labs | Lot CR-3XAG10-2605-1 · Report ACC-2026-2645 |
| May 11, 2026 | Tesamorelin | HPLC purity | PASS | 99.47% | ILS Labs | Lot CR-TSM20-0307-1 · Report ACC-2026-2073 |
| May 11, 2026 | PT-141 | HPLC purity | PASS | 99.93% | ILS Labs | Lot CRPT-10-2605-1 · Report ACC-2026-2067 |
| May 11, 2026 | MOTS-c | HPLC purity | PASS | 99.91% | ILS Labs | Lot CR-MTS10-0309-1 · Report ACC-2026-2076 |
| May 11, 2026 | EPITALON | HPLC purity | PASS | 99.08% | ILS Labs | Lot CRET-50-0212-1 · Report ACC-2026-2079 |
| May 11, 2026 | NAD+ | HPLC purity | PASS | 99.44% | ILS Labs | Lot CR-NJ500-0309-1 · Report ACC-2026-2070 |
| Apr 22, 2026 | GHK-Cu | HPLC purity | PASS | 99.91% | ILS Labs | Lot CRGHK-100-2604-1 · Report ACC-2026-0951 |
| Apr 22, 2026 | Triple Agonist | HPLC purity | PASS | 99.92% | ILS Labs | Lot CRRT-30-2604-2 · Report ACC-2026-0955 |
| Apr 22, 2026 | Cagrilintide | HPLC purity | PASS | 99.69% | ILS Labs | Lot CRCAG-5-2604-1 · Report ACC-2026-0947 |
| Apr 22, 2026 | Klow | HPLC purity | PASS | 99.47% | ILS Labs | Lot CRKLO-80-2604-1 · Report ACC-2026-0943 |
Disclosed Labs